Cardiomiopatía periparto temprana complicada con accidente cerebrovascular cardioembólico: A propósito de un caso

Málaga, Germán; Quintana, José; Posadas, David; Quispe, Jorge; Rotta, Aida
April 2010
Revista Medica Herediana;abr-jun2010, Vol. 21 Issue 2, p97
Academic Journal
No abstract available.


Related Articles

  • Selective Use of Two-Dimensional Echocardiography in Stroke Syndromes. Larson, Eric B.; Stratton, John R.; Pearlman, Alan S. // Annals of Internal Medicine;Jul81, Vol. 95 Issue 1, p112 

    Editorial. Comments on advances in the diagnostic methods for the study of patients with cerebrovascular diseases, particularly on the two-dimensional (2D) echocardiography. Background on studies dealing with the use of 2D echocardiography in patients with stroke; Views on the efficacy of...

  • Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. Gandolfo, C.; Balestrino, M.; Burrone, A.; Sette, M.; Finocchi, C. // Journal of Neurology;Jun2008, Vol. 255 Issue 6, p796 

    Several studies have reported that oral anticoagulant prophylaxis (OAC) is under-used in patients with atrial fibrillation (AF). This study investigated the attitude to prescribing OAC in patients with AF observed in an Italian Stroke Unit (SU) and the severity of ischemic stroke due to AF in...

  • Embolic stroke, sinus rhythm and left atrial mechanical function Lombardo, Renzo M.R.; Reina, Caterina; Abrignani, Maurizio G.; Braschi, Annabella; De Castro, Stefano // European Journal of Echocardiography;Oct2006, Vol. 7 Issue 5, p401 

    Abstract: A 64-year-old man manifested a stroke two years after restoration of sinus rhythm through a radiofrequency catheter ablation. Transesophageal echocardiography demonstrated the presence of a thrombus in the left atrial appendage. Left atrial volumes and different parameters of atrial...

  • Does Long-Term Anticoagulation Improve Function After Stroke? Brewer, Dan // American Family Physician;6/1/2003, Vol. 67 Issue 11, p2317 

    Presents a clinical scenario and question based on a study which assessed the effect of long-term anticoagulation following presumed non-cardioembolic ischemic stroke or transient ischemic attack. Implications for clinical practice.

  • Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms. Nara, Mizuho; Komatsuda, Atsushi; Fujishima, Masumi; Fujishima, Naohito; Nara, Miho; Iino, Takako; Ito, Hiroshi; Sawada, Ken-ichi; Wakui, Hideki // Clinical & Experimental Nephrology;Aug2011, Vol. 15 Issue 4, p582 

    A 22-year-old woman, who often carried heavy books, was admitted for evaluation of hyperreninemic hypertension. Two months prior to admission, she noted leg edema. Radiological examinations revealed bilateral renal infarction with no other abnormal findings. An echocardiography showed a patent...

  • Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial. Oldgren, Jonas; Alings, Marco; Darius, Harald; Diener, Hans-Christoph; Eikelboom, John; Ezekowitz, Michael D.; Kamensky, Gabriel; Reilly, Paul A.; Sean Yang; Yusuf, Salim; Wallentin, Lars; Connolly, Stuart J. // Annals of Internal Medicine;11/15/2011, Vol. 155 Issue 10, p660 

    Background: CHADS2 is a simple, validated risk score for predicting the risk for stroke in patients with atrial fibrillation not treated with anticoagulants. There are sparse data on the risk for thrombotic and bleeding complications according to the CHADS2 score in patients receiving...

  • Warfarin vs Clopidogrel Plus Aspirin for Atrial Fibrillation. DiMarco, John P. // Clinical Cardiology Alert;Jan2008, Vol. 27 Issue 1, p4 

    The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation. ACTIVE W enrolled 6706...

  • Apixaban reduced risk for stroke, embolism in patients ineligible for vitamin K antagonist. Smith, Wade S.; Furie, Bruce // Hem/Onc Today;5/25/2011, Vol. 12 Issue 10, p34 

    The article discusses a study funded by Bristol-Myers Squibb and Pfizer which showed that apixaban reduced the risk for stroke or systemic embolism without simultaneously increasing risk for major bleeding in patients ineligible for vitamin K antagonist.

  • Utility of Transesophageal Echocardiography in Determining the Source of Arterial Embolization. Mariano, Myron C.; Gutierrez, Charles J.; Alexander, Jason Q.; Katz, Steven G.; Kohl, Roy D.; Roth, Fernando // American Surgeon;Sep2002, Vol. 68 Issue 9, p765 

    Arterial embolism is frequently the product of a cardiac source. Arterial-arterial embolization and paradoxical embolization also occur. Failure to identify the point of origin may subject the patient to an important incidence of preventable events. Conventional echocardiography is insensitive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics